Pembrolizumab Plus Vorinostat a Potential Combo for Lung Cancer - DocWire News

Pembrolizumab Plus Vorinostat a Potential Combo for Lung Cancer  DocWire News

A phase I/Ib study published in Clinical Cancer Research found that treatment with the immune checkpoint inhibitor (ICI) pembrolizumab plus the histone.



Comments

Popular posts from this blog

Oncology: The disease, dynamics & challenges of market research

A Review of the Etiology and Epidemiology of Bladder Cancer: All ...

Lung Cancer Among People Who Never Smoked